Supplementary Figure S1 . Flow chart of the synthesis of the αCD22 Ab-ASO conjugate.
Supplementary Figure S3 . MXD3 knockdown in Reh cells is confirmed by immunocytochemistry and immunoblotting. Reh cells were treated with the αCD22 Ab-MXD3 or -control ASO conjugate (0.5 μmol/L of the Ab in the conjugate). MXD3 protein expression was measured on the same samples at 4 and 24 h after the treatment. Significant MXD3 protein knockdown was observed in the cells treated with the αCD22 Ab-MXD3 conjugate compared with untreated or cells treated with αCD22 Ab-control ASO conjugate. (A) Immunocytochemistry results are shown. The overlay pictures show a composite image of both MXD3 protein (with Alexa488) and nuclei (with DAPI). Images were acquired at 40× magnification/1.4 numerical aperture at room temperature using a Nikon Ti-U inverted microscope and NIS-Elements BR software. Scale bar indicates 50 μm. The images shown are from one representative experiment out of three experiments. (B) Mean fluorescence intensity (MFI) was used to quantify MXD3 protein expression from (A). Each bar represents the average MFI of all measured cells per treatment type from three independent experiments. Error bars represent SEM (n = 3). Average MXD3 knockdown in the cells treated with αCD22 Ab-MXD3 ASO conjugate, compared with untreated or αCD22 Ab-control ASO conjugate, was 56% and 55% at 4 h and 52% and 54% at 24 h, respectively (** ANOVA p < 0.001, significant differences from multiple comparisons shown). (C) Immunoblotting results from the same experiment in (A) are shown. Histone H3 was used as an internal control. The images shown are from one representative experiment out of three experiments. (D) MXD3 expression levels relative to those in untreated cells (after corrected with Histone H3 expression levels) are shown. Error bars represent SEM (n = 3). The results are average data from three independent experiments (same as in B). MXD3 knockdown in the cells treated with αCD22 Ab-MXD3 ASO conjugate, compared with untreated or αCD22 Ab-control ASO conjugate, were 81% and 77% at 4 h and 85% and 84% at 24 h, respectively (Overall ANOVA ***p < 0.001, significant differences from multiple comparisons shown).
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